(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OPTIDOSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

OPTIDOSE

ST13

US500000086164950

Class

5, 40

Filing

86164950

Registration

4800458

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/19/2026

Trademark type

Word

Nice classes

5, 40

Filing date

01/14/2014

Registration date

08/25/2015

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/25/2026

Last transaction

05/19/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/01/2011

First use in commerce

10/01/2011

Drawing code

4

Owner type

03

Owner location

Somerset, NJ, US

Examiner

SPARACINO, MARK V

Holders and representatives

Holders

CATALENT PHARMA SOLUTIONS, INC.

Representatives

Vanessa A. Ignacio, Esq. LOWENSTEIN SANDLER LLP

Technical classification

Nice Classes

Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Drug delivery agents in the form of tablets that provide controlled and/or immediate release of the active ingredients for a wide variety of pharmaceuticalsincluding combination products and dividable tablets

Class 40

Contract manufacturing in the field of pharmaceuticals and pharmaceutical delivery agents

Publications

History of USPTO decisions and trademark events.

33 publications found

NP89

NOTICE OF ACCEPTANCE OF PARTIAL SEC. 8 & 9 EMAILED

04/25/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/25/2026

9G8P

REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8

04/25/2026

8PRT

REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED

04/25/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/25/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

02/19/2026

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

12/25/2024

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/25/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/14/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/13/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/13/2022

E815

TEAS SECTION 8 & 15 RECEIVED

02/25/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/25/2020

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

05/22/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

08/25/2015

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/18/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/17/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/16/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/14/2015

IUAF

USE AMENDMENT FILED

06/16/2015

EISU

TEAS STATEMENT OF USE RECEIVED

06/16/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/24/2014

EX1G

SOU EXTENSION 1 GRANTED

12/22/2014

EXT1

SOU EXTENSION 1 FILED

12/22/2014

EEXT

SOU TEAS EXTENSION RECEIVED

12/22/2014

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/15/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/20/2014

PUBO

PUBLISHED FOR OPPOSITION

05/20/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/30/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/16/2014

DOCK

ASSIGNED TO EXAMINER

04/16/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2014

NWAP

NEW APPLICATION ENTERED

01/17/2014

Continuous trademark protection

Get notified about every new filing that threatens OPTIDOSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.